Regulus Therapeutics Inc. | Business Contracts

Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)

Description of Common Stock (Filed With SEC on March 23, 2023)

Assignment and Assumption of Lease, dated February 11, 2021, by and between the Registrant and Turning Point Therapeutics, Inc (Filed With SEC on March 9, 2021)

Employment Agreement between the Registrant and Denis Drygin (Filed With SEC on March 9, 2021)

Second Amendment to Second Amended and Restated Collaboration and License Agreement, dated August 25, 2020, by and between the Registrant and Sanofi (Filed With SEC on November 5, 2020)

Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)

Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)

Regulus Therapeutics Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on August 11, 2022)

Form of Common Stock Certificate of the Registrant (Filed With SEC on August 11, 2022)

Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)

Description of Common Stock (Filed With SEC on March 11, 2022)

Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)

Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)

Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)

Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and among the Registrant and Oxford Finance, LLC (Filed With SEC on March 11, 2022)

Eleventh Amendment to Loan and Security Agreement, dated December 31, 2021, by and between the Company and Oxford Finance LLC (Filed With SEC on January 5, 2022)

Lease Agreement, dated February 11, 2021, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on March 9, 2021)

Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 9, 2021)

Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020 (Filed With SEC on March 9, 2021)

Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019 (Filed With SEC on March 9, 2021)

Form of Common Stock Purchase Warrant (Filed With SEC on December 4, 2020)

Securities Purchase Agreement, dated December 1, 2020, by and among the Company and the Purchasers (Filed With SEC on December 4, 2020)

Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on November 5, 2020)

Ninth Amendment to Loan and Security Agreement, dated May 1, 2020, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on May 14, 2020)

Description of Common Stock (Filed With SEC on March 12, 2020)

Employment Agreement, dated August 30, 2019, by and between the Registrant and Cris Calsada (Filed With SEC on November 12, 2019)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on November 12, 2019)

Lease Agreement, dated June 19, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on August 8, 2019)

Regulus Therapeutics Inc. 2019 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the Registrants Current Report on Form 8-K (File No. 001-35670, filed with the... (Filed With SEC on August 8, 2019)

First Amendment to Lease, dated June 19, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on August 8, 2019)

Consulting agreement, dated July 26, 2019, by and between the Registrant and Daniel R. Chevallard (Filed With SEC on August 8, 2019)

Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada (Filed With SEC on July 30, 2019)

Seventh Amendment to Loan and Security Agreement, dated April 9, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on May 10, 2019)

Employment Agreement between the Registrant and Christopher Aker, dated July 24, 2018 (Filed With SEC on May 10, 2019)

Eighth Amendment to Loan and Security Agreement, dated May 3, 2019, by and between the Company and Oxford Finance LLC (Filed With SEC on May 9, 2019)

Securities Purchase Agreement, dated May 3, 2019, by and among the Company and the Purchasers (Filed With SEC on May 9, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on May 9, 2019)

Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc (Filed With SEC on March 18, 2019)

Lease Agreement, dated February 25, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on March 18, 2019)

First Amendment to Second Amended and Restated Collaboration and License Agreement, dated November 5, 2018, by and between the Registrant and Sanofi (Filed With SEC on March 18, 2019)

Second Amendment to Lease Agreement, dated February 25, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC (Filed With SEC on March 18, 2019)

Sixth Amendment to Loan and Security Agreement, dated March 7, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 18, 2019)

Fourth Amendment to Loan and Security Agreement, dated November 5, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 18, 2019)

Fifth Amendment to Loan and Security Agreement, dated January 31, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on February 1, 2019)

Regulus Therapeutics Inc. (44)